• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Golub Capital Provides One-Loan Debt Facility to Support the Acquisition of CRH Healthcare by Freeman Spogli & Co.

Share:

December 24, 2018

Golub Capital recently announced that, as Administrative Agent, Sole Lead Arranger and Sole Bookrunner, it provided a GOLD facility to support the acquisition of CRH Healthcare by Freeman Spogli & Co., in partnership with CRH management. GOLD financings are Golub Capital One-Loan Debt facilities.

Headquartered in Atlanta, Georgia, CRH is a patient-focused operator of urgent care centers in Alabama, Florida and Georgia. CRH’s centers are conveniently open seven days a week and provide walk-in care for injury, illness and minor emergencies, as well as family care to keep both parents and children healthy. In addition to a professional and courteous staff, each center has extensive lab capabilities and digital x-rays onsite, allowing patients to be seen for nearly all non-life threatening medical issues without the long wait or high costs of an emergency room visit.

“We proudly support Freeman Spogli and management in connection with the investment in CRH,” said Troy Oder, Managing Director at Golub Capital. “Freeman Spogli has a long track record of partnering with management to expand consumer-oriented, multi-location businesses, and we believe they are uniquely suited to add significant value to the CRH platform.”

“Golub Capital has proven to be a flexible and reliable financing partner to many of our portfolio companies, and we are excited to be partnering with them again in CRH,” said Christian Johnson, Partner at Freeman Spogli & Co. “Throughout our longstanding relationship, Golub Capital has provided us with unique financing solutions, as well as additional support for our companies throughout our ownership.”

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Date: December 2018

Source: Market insider

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • NeuBase Therapeutics Announces Acquisition of Gene Modulating Technology from Vera TherapeuticsNeuBase Therapeutics Announces Acquisition of Gene Modulating Technology from Vera Therapeutics
  • Sony Study Reinforces Importance of Remote MonitoringSony Study Reinforces Importance of Remote Monitoring
  • Global Health Care Deals Expected to Top US$400 Billion This Year, says Law Firm Baker McKenzieGlobal Health Care Deals Expected to Top US$400 Billion This Year, says Law Firm Baker McKenzie
  • Panbela Therapeutics, Inc. Closes Acquisition of Cancer Prevention Pharmaceuticals, Inc.Panbela Therapeutics, Inc. Closes Acquisition of Cancer Prevention Pharmaceuticals, Inc.
  • Strongbridge Biopharma plc Announces Completion of Acquisition by Xeris Pharmaceuticals, Inc.Strongbridge Biopharma plc Announces Completion of Acquisition by Xeris Pharmaceuticals, Inc.
  • Adamis Pharmaceuticals Announces Closing of the Merger with DMK PharmaceuticalsAdamis Pharmaceuticals Announces Closing of the Merger with DMK Pharmaceuticals
  • Biotage Acquires ATDbio and Strengthens Its Position in DNA and RNA Oligonucleotide Synthesis and PurificationBiotage Acquires ATDbio and Strengthens Its Position in DNA and RNA Oligonucleotide Synthesis and Purification
  • Kyruus Raises $42M in Series DKyruus Raises $42M in Series D

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications